Ocugen’s Chief Scientific Officer to Present Gene Therapy Innovations at Upcoming Conference

NImmune and BioTherapeutics Collaborate to Advance Precision Medicine Development

Life Sciences Organizations Unlock Real-World Data to Advance Precision Therapies and Diagnostics for Patients

Immuneel Therapeutics Names Amit Mookim as New CEO

Paige Introduces Alba: The AI-Powered Clinical Co-Pilot Transforming Diagnostics and Treatment in Pathology and Oncology

SOPHiA GENETICS and Precision for Medicine Unveil Validated Novel Clinical Trial Assay at World Clinical Biomarkers & CDx 2024

Genetic Leap and Lilly Partner to Accelerate Genetic Medicine Development Through AI

Qiagen and Eli Lilly Partner to Develop Alzheimer's Risk Diagnostic Panel

Leapfrog Bio Publishes Breakthrough Validation of Precision PGx Platform™ in *Nature PJ Precision Oncology*

ArsenalBio Secures $325M in Series C Funding, Backed by Nvidia and Regeneron

The Role of Newborn Screening in Public Health

Apollo Hospitals Unveils Research Academy to Pioneer Global Healthcare Innovation

JMI Unveils World’s First AI-Powered Oral Cancer Database

BillionToOne Integrates Semaphore Solutions' Labbit LIMS into Precision Oncology Diagnostics Labs

European Commission Approves Merck’s KEYTRUDA® and Padcev® as First-Line Therapy for Unresectable or Metastatic Urothelial Carcinoma in Adults.

Home
/
update
/
details

SUNACT Cancer Institute Launches in Thane to Offer Allogeneic CAR-T Cell Therapy

NextEdge Admin

24 Jul 2024

2 min 31 sec

Actor and cancer survivor Mahima Chaudhry recently inaugurated SUNACT Cancer Institute, India's first chain of super-specialized cancer clinics featuring GMP Modular Units. The institute, located at Tieten Medicity Hospital in Thane, is led by renowned oncologists Professor Dr. Vijay Patil and Dr. Ashay Karpe. It offers allogeneic CAR-T Cell Therapy, a cutting-edge treatment that uses donor cells and is effective against solid-state tumors, which make up 99% of cancer cases. This therapy significantly reduces treatment time compared to the autologous version, which is primarily for blood cancers.

SUNACT Cancer Institute aims to advance cancer treatment in India with innovative research and personalized patient care. It provides various therapies, including CAR-T (both allogeneic and autologous), Stem Cell/Bone Marrow Transplants, Gamma Delta T-Cells, Gene Therapy (CRISPR and Gene Editing), Immunotherapy, and advanced chemotherapy.

Dr. Vijay Patil, SUNACT's founder, expressed his commitment to eradicating cancer and highlighted the institute's success in completing India's first allogeneic CAR-T cell therapy at a fraction of the cost compared to Western countries. This breakthrough is expected to save many lives.

Mahima Chaudhry praised the advancements in cancer treatment and expressed gratitude to the medical professionals for their selfless service. She congratulated the entire team for establishing and running the pioneering facility.

SUNACT Cancer Institute plans to open more specialized cancer centers across India, including locations in Mumbai, Delhi/NCR, Bangalore, Pune, Kolkata, and Chennai. By collaborating with international labs, SUNACT aims to provide advanced cancer treatments at affordable costs in underserved markets worldwide, including the Middle East, Africa, and South Asia.